Archive: Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute.
Worried About Big Pharma? Then Reduce the FDA’s Regulatory Power.
To compete for FDA attention, drug makers now needed a way to navigate new safety hurdles to have their products approved.
San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke
Government efforts to regulate away vices can also motivate more dangerous or unhealthy behaviors.
Right-to-Try Legislation Helps Patient Battling Bone Cancer
After receiving access to experimental treatments, Natalie’s condition improved substantially.
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Although much work remains to reverse the DEA’s overzealous scheduling system, Ketamine-based treatment for mental illness is another step in the right direction.
Healthcare Needs Price Competition, Not Just Transparency
Efforts to make healthcare costs more transparent are a good start. But transparency is no substitute for competition.
If Teen Vaping Is Bad, the Alternative Is Worse
The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.